Article
TEAD transcription factor family emerges as a promising therapeutic target for oral squamous cell carcinoma
4 Oct 2024
Abstract excerpt
The treatment of oral squamous cell carcinoma (OSCC) remains a significant difficulty, as there has been no improvement in survival rates over the past fifty years. Hence, exploration and confirmation of new dependable treatment targets and biomarkers is imperative for OSCC therapy. TEAD transcription factors are crucial for integrating and coordinating multiple signaling pathways that are essential for embryonic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
